Patent ID: 9206201
Filing Date: 2015-12-08
Classification: A61K,A61P,C07F

Abstract:
1. A compound of general formula 1, and pharmaceutically acceptable salts thereof, wherein, a) ‘Y’═O, S, NH or NR, wherein R=alkyl moiety, aryl moiety, heteroaryl moiety, cyclic aliphatic ring or an aromatic system; b) wherein n=0 or 1; c) wherein R wherein, R, R′, R″ are independently selected from a group consisting of alkyl moiety, aryl moiety, heteroaryl moiety and cyclic aliphatic ring, wherein the cyclic aliphatic ring is selected from a group consisting of cyclopropyl, cyclobutyl, cyclopentyl and cyclohexyl ring and wherein the cyclic aliphatic ring has substitutions, wherein the alkyl moiety is selected from a group consisting of methyl, ethyl, propyl, isopropyl, butyl and isobutyl, and wherein the aryl or heteroaryl moiety has substitutions selected from a group consisting of halo, alkyl, nitro, amino, and sulphonyl substitutions; d) wherein R wherein R, R′, R″ are independently selected from a group consisting of alkyl moiety, aryl moiety, heteroaryl moiety and cyclic aliphatic ring with substitutions, wherein the alkyl moiety is selected from a group consisting of methyl, ethyl, propyl, isopropyl, butyl and isobutyl, and wherein the aryl or heteroaryl moiety has substitutions selected from a group consisting of halo, alkyl, nitro, amino, and sulphonyl substitutions; wherein the alkyl substituent is selected from a group consisting of methyl, ethyl, and propyl, e) wherein R f) wherein R6 and r7 ae independently a methyl group, wherein R, R′, R″ are independently selected from a group consisting of alkyl moiety, aryl moiety, heteroaryl moiety and cyclicaliphatic ring with substitutions.